Details, Fiction and Ponsegromab
All enrolled patients who acquired at the very least a person dose of zosuquidar or placebo all through induction had been monitored for the event of adverse gatherings (439 people, 219 on zosuquidar and 210 on placebo). The most common adverse functions have been related to the period of extended and significant myelosuppression as is anticipated